Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap
- PMID: 21478047
- DOI: 10.1016/j.oraloncology.2011.03.022
Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap
Abstract
Bisphosphonate related osteonecrosis of the jaw (BRONJ) is a side effect that may emerge due to a long-term bisphosphonate therapy. Although the timely diagnosis and initiation of treatment are associated with good outcome results, extended cases require whole parts of the jaw to be resected. A possible treatment option is the bony reconstruction of the jaw using microvascular bone flaps. We report, for the first time, the development of a bisphosphonate related osteonecrosis in a microvascular iliac bone graft, a reconstruction that was performed following a partial mandibulectomy due to BRONJ stage III. The observation of BRONJ manifestation in an osseous microvascular transplant is a novel finding that sheds new light on current pathogenesis theories that surround this entity. Furthermore, it is hypothesized that BRONJ is able to progress to adjacent bone. In addition, bone reconstruction in patients suffering from BRONJ may be seen more critically.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006. J Oral Maxillofac Surg. 2009. PMID: 19371819
-
Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.J Oral Maxillofac Surg. 2011 Jan;69(1):84-91. doi: 10.1016/j.joms.2010.07.014. Epub 2010 Oct 25. J Oral Maxillofac Surg. 2011. PMID: 20971542
-
Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem.Anticancer Res. 2011 Jun;31(6):2313-8. Anticancer Res. 2011. PMID: 21737657
-
Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?J Oral Maxillofac Surg. 2010 May;68(5):1158-61. doi: 10.1016/j.joms.2009.07.079. J Oral Maxillofac Surg. 2010. PMID: 20138420 Review.
-
The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70. doi: 10.1016/j.joms.2009.01.007. J Oral Maxillofac Surg. 2009. PMID: 19371816 Review.
Cited by
-
Mandibulectomy Reconstruction with Pectoralis Major Island Flap Associated with Primary Reconstruction Plate for Mandibular Medication-Related Osteonecrosis.Curr Health Sci J. 2021 Jan-Mar;47(1):117-122. doi: 10.12865/CHSJ.47.01.19. Epub 2021 Mar 31. Curr Health Sci J. 2021. PMID: 34211758 Free PMC article.
-
Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.J Bone Miner Res. 2012 Oct;27(10):2130-43. doi: 10.1002/jbmr.1669. J Bone Miner Res. 2012. PMID: 22623376 Free PMC article.
-
Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?J Transl Med. 2013 Dec 11;11:303. doi: 10.1186/1479-5876-11-303. J Transl Med. 2013. PMID: 24330728 Free PMC article. Review.
-
Microsurgical Reconstruction of the Jaws Using Vascularised Free Flap Technique in Patients with Medication-Related Osteonecrosis: A Systematic Review.Biomed Res Int. 2018 Jun 7;2018:9858921. doi: 10.1155/2018/9858921. eCollection 2018. Biomed Res Int. 2018. PMID: 29977926 Free PMC article.
-
Surgical treatment of severe medication-related osteonecrosis of the jaw.Hua Xi Kou Qiang Yi Xue Za Zhi. 2023 Feb 1;41(1):43-51. doi: 10.7518/hxkq.2023.01.006. Hua Xi Kou Qiang Yi Xue Za Zhi. 2023. PMID: 38596940 Free PMC article. Chinese, English.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical